landiolol has been researched along with atropine in 2 studies
| Studies (landiolol) | Trials (landiolol) | Recent Studies (post-2010) (landiolol) | Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) |
|---|---|---|---|---|---|
| 311 | 85 | 176 | 26,711 | 1,259 | 1,697 |
| Protein | Taxonomy | landiolol (IC50) | atropine (IC50) |
|---|---|---|---|
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 21.41 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.012 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0067 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0007 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0009 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0015 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0021 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.354 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, F; Nonaka, A; Suzuki, S | 1 |
| Kim, C; Kitamura, A; Nakanishi, K; Sakamoto, A; Sato, C; Yokozuka, M | 1 |
2 other study(ies) available for landiolol and atropine
| Article | Year |
|---|---|
[The effects of continuous infusion of landiolol on heart rate changes after neostigmine-atropine administration during recovery from general anesthesia].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anesthesia Recovery Period; Anesthesia, General; Atropine; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Neostigmine; Urea | 2006 |
Incessant non-sustained ventricular tachycardia after stimulus of electroconvulsive therapy with atropine premedication?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine; Depressive Disorder, Major; Electrocardiography; Electroconvulsive Therapy; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Preanesthetic Medication; Recurrence; Retreatment; Tachycardia, Ventricular; Urea; Ventricular Premature Complexes | 2007 |